Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Kojic Acid
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Menarini
Deal Size : Inapplicable
Deal Type : Inapplicable
Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma
Details : Kojic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Melanosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 18, 2023
Lead Product(s) : Kojic Acid
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Menarini
Deal Size : Inapplicable
Deal Type : Inapplicable